Screen Shot 2022-03-19 at 4.55.42 PM

Medstream360 members only

To view this video and learn more about the procedure please Login or Register.
Membership is free!

The Mount Sinai Hospital

1468 Madison Avenue, New York,
New York 10029

Transfemoral ViV TAVR using 23mm Evolut Pro+ Valve with Sentinel Cerebral Embolic Protection Device

Miscellaneous Structural

73-year-old male presents with worsening NYHA Class III symptoms of heart failure for the last 4-5 months. Past medical history is significant for severe restrictive lung disease, home oxygen use, HTN, HLD, IDDM, OA, CAD and aortic stenosis s/p AVR and CABG (in 2012 with 21mm MitroFlow bio-prosthetic valve and LIMA to LAD, SVG to OM, RPDA, RPL). Recent TT echocardiogram revealed LVEF of 46%, moderate TR/MR, abnormal aortic bio-prosthesis with moderate to severe regurgitation and mean gradient of 25mmHg. His STS PROM risk for redo-AVR was calculated at 9.3%. Heart Team evaluation found him to be at high risk for SAVR. Now planned for trans-femoral ViV TAVR via right percutaneous femoral arterial access using a 23mm Evolut Pro + valve with Sentinel cerebral embolic protection device.


Case Presentation


Lorem ipsum dolor sit amet consectetur adipisicing elit. A, dignissimos?